Sergio J. Romero-Tapia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sergio J. Romero-Tapia has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jose Antonio Castro-Rodriguez
Department of Pediatric Pulmonology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile
2 shared publications - Victor Gonzalez-Uribe
AlergiaMx, Benito Juarez, Mexico City, Mexico; Facultad Mexicana de Medicina, Universidad La Salle Mexico, Tlalpan, Mexico City, Mexico
2 shared publications C. Virgen-Ortega
Private Medicine, Villahermosa, Tabasco, Mexico
1 shared publicationD.P. Bulnes-Mendizabal
Hospital de Alta Especialidad del Niño "Dr. Rodolfo Nieto Padrón", Villahermosa, Tabasco, Mexico
1 shared publicationH.H. Cámara-Combaluzier
Hospital de Alta Especialidad del Niño "Dr. Rodolfo Nieto Padrón", Villahermosa, Tabasco, Mexico
1 shared publicationM.A. Baeza-Bacab
Faculty of Medicine, University Autonomous of Yucatán, Mérida, Yucatán, Mexico
1 shared publication
Latest Publications
- Open Access
- 26 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (19) , 6207
Asthma Phenotypes in the Era of Personalized Medicine
Asthma is a widespread disease affecting approximately 300-million people globally. This condition leads to significant morbidity, mortality, and economic strain worldwide. Recent clinical and laboratory research advancements have illuminated the immunological factors contributing to asthma. As of now, asthma is understood to be a heterogeneous disease. Personalized medicine involves categorizing asthma by its endotypes, linking observable characteristics to specific immunological mechanisms. Identifying these endotypic mechanisms is paramount in accurately profiling patients and tailoring therapeutic approaches using innovative biological agents targeting distinct immune pathways. This article presents a synopsis of the key immunological mechanisms implicated in the pathogenesis and manifestation of the disease’s phenotypic traits and individualized treatments for severe asthma subtypes.
- 26 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (19) , 6207
Open AccessAsthma Phenotypes in the Era of Personalized Medicine
Asthma is a widespread disease affecting approximately 300-million people globally. This condition leads to significant morbidity, mortality, and economic strain worldwide. Recent clinical and laboratory research advancements have illuminated the immunological factors contributing to asthma. As of now, asthma is understood to be a heterogeneous disease. Personalized medicine involves categorizing asthma by its endotypes, linking observable characteristics to specific immunological mechanisms. Identifying these endotypic mechanisms is paramount in accurately profiling patients and tailoring therapeutic approaches using innovative biological agents targeting distinct immune pathways. This article presents a synopsis of the key immunological mechanisms implicated in the pathogenesis and manifestation of the disease’s phenotypic traits and individualized treatments for severe asthma subtypes.
- Open Access
- 24 July 2023
- Published by MDPI AG in Preprints.org
Asthma Phenotypes in the Era of Personalized Medicine
Asthma is a prevalent disease that around 300 million worldwide, resulting in substantial morbidity, mortality, and economic burden on a global scale. New clinical and laboratory research has shed light on the immunology causing asthma. Asthma is now recognized as a heterogeneous disease. A personalized medicine is based on the classification of asthma by endotype by linking observable characteristics to immunological mechanisms. Identifying endotype mechanisms is essential for better characterizing patients and personalizing therapeutic approaches with novel biological agents that target specific immune pathways. This article provides a summary of the major immunological mechanisms involved in the pathogenesis and emergence of the disease's phenotypic features, as well as the individualized treatment for severe asthma subtypes
- 24 July 2023
- Published by MDPI AG in Preprints.org
Open AccessAsthma Phenotypes in the Era of Personalized Medicine
Asthma is a prevalent disease that around 300 million worldwide, resulting in substantial morbidity, mortality, and economic burden on a global scale. New clinical and laboratory research has shed light on the immunology causing asthma. Asthma is now recognized as a heterogeneous disease. A personalized medicine is based on the classification of asthma by endotype by linking observable characteristics to immunological mechanisms. Identifying endotype mechanisms is essential for better characterizing patients and personalizing therapeutic approaches with novel biological agents that target specific immune pathways. This article provides a summary of the major immunological mechanisms involved in the pathogenesis and emergence of the disease's phenotypic features, as well as the individualized treatment for severe asthma subtypes